How Will Proposed Changes To The Nice Highly Specialised Technology Evaluation Process Impact Patient Access To Innovative Drugs for Rare Diseases?
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1781
https://www.valueinhealthjournal.com/article/S1098-3015(17)32115-0/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
1615
First Page :
A694
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32115-0&doi=10.1016/j.jval.2017.08.1781